Session 5: Featured Research Presentations- Best Submitted Abstracts (Non-CME)
Chairs: Markus Amann, PhD, U of U; Ademuyiwa Aromolaran, PhD, U of U; Roberta Florido, MD, U of U; Eleni Tseliou, MD/PhD, U of U
- Heart-Brain Communication of Antioxidant Signals in Heart Failure. Irving H. Zucker, PhD, U of Nebraska
- Multi-modal biomimetic human translational models for understanding myocardial load response. Michael Ibrahim, MD, PhD, U Penn
- Role of microcirculation in assessing myocardial recovery. Nir Uriel, MD, Columbia
- Innovation in stem cell therapy for HF patients. Gregor Poglajen, MD, U of Ljubljana, Slovenia
- LV unloading and its effect on RV contractility and RV-pulmonary coupling in LVAD recipients. Steven Hsu, MD, Johns Hopkins
- Ventricular restoration to mediate reverse remodeling: AccuCinch trial. Ulrich Jorde, MD, Montefiore/Einstein
- Innovation in recovering donor hearts: insights from the Donor Heart Study. Kiran Khush, MD, Stanford
- Safety, tolerability and pharmacodynamics of the dipeptidyl peptidase 3 antibody Procizumab in a first-in-human, placebo-controlled, phase 1 trial. Karine Bourgeois, PhD, CSO 4TEEN4 Pharmaceuticals